Russia approves its third COVID-19 vaccine, CoviVac - (Financial Post via NewsPoints Desk)

  • Russia approved the coronavirus vaccine CoviVac, which is produced by the Chumakov Centre, making it the third COVID-19 vaccine authorised in the country, as reported in Financial Post.

  • CoviVac, which has not yet gone through large-scale studies, is a "whole-virion" vaccine given in two doses, 14 days apart,

  • According to virologist Alexander Chepurnov, as CoviVac includes all elements of the virus, it may create a broader immune response that is likely to protect against any variants.

  • Aidar Ishmukhametov, director of the Chumakov Centre, said CoviVac has been tested for safety on 200 people aged between 18 and 60, while mid-stage trials to test immune responses are ongoing.

To read more NewsPoints articles, click here.

Reference Articles